FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leo Luznik

Research Profile

Disorders

Procedures

Chemicals & Drugs

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jennifer A Kanakry; Yvette L Kasamon; Leo Luznik; Lode J Swinnen; HEATHER SYMONS; Hua-Ling Tsai; F. JAVIER BOLANOS MEADE; JANICE DAVIS SPROUL; Ephraim J Fuchs; Nilanjan Ghosh; Douglas E Gladstone; Christopher D Gocke; Richard J Jones; Richard F Ambinder
Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.
Douglas E Gladstone; Richard J Jones; Yvette L Kasamon; Karen E King; Robert A Brodsky; Ephraim J Fuchs; Leo Luznik; Andrea A Zachary; Mary S Leffell
Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.
F. JAVIER BOLANOS MEADE; Vincent T Ho; John E Levine; Brent R Logan; Leo Luznik; Daniel J Weisdorf; Juan Wu; Amin Alousi
Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leo Luznik (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer A Kanakry; Yvette L Kasamon; Leo Luznik; Lode J Swinnen; HEATHER SYMONS; Hua-Ling Tsai; F. JAVIER BOLANOS MEADE; JANICE DAVIS SPROUL; Ephraim J Fuchs; Nilanjan Ghosh; Douglas E Gladstone; Christopher D Gocke; Richard J Jones; Richard F Ambinder
Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(4):602-6.
2013: Douglas E Gladstone; Richard J Jones; Yvette L Kasamon; Karen E King; Robert A Brodsky; Ephraim J Fuchs; Leo Luznik; Andrea A Zachary; Mary S Leffell
Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(4):647-52.
2013: F. JAVIER BOLANOS MEADE; Vincent T Ho; John E Levine; Brent R Logan; Leo Luznik; Daniel J Weisdorf; Juan Wu; Amin Alousi
Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):481-5.
2013: Amer Zeidan; Joseph Aoki; F. JAVIER BOLANOS MEADE; Michael J Borowitz; Ephraim J Fuchs; Richard J Jones; Yvette L Kasamon; Leo Luznik; Lode J Swinnen; HEATHER SYMONS; Richard F Ambinder
Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma.
Leukemia & lymphoma 2013;54(3):655-7.
2012: Leo Luznik; Paul V O'Donnell; Ephraim J Fuchs
Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.
Seminars in oncology 2012;39(6):683-93.
2012: F. JAVIER BOLANOS MEADE; Ephraim J Fuchs; Christopher Jordan Gamper; Richard J Jones; Sophie Lanzkron; Leo Luznik; Robert A Brodsky
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.
Blood 2012;120(22):4285-91.
2012: Kelly Norsworthy; Leo Luznik; Ivana Gojo
New treatment approaches in acute myeloid leukemia: review of recent clinical studies.
Reviews on recent clinical trials 2012;7(3):224-37.
2012: Mathangi Srinivasan; Patricia A Taylor; Joseph H Antin; Jeffrey L Browning; Ryan Flynn; Leo Luznik; William Murphy; Angela Panoskaltsis-Mortari; Andrew Price; Ann Ranger; Jerome Ritz; Mark J Shlomchik; Bruce R Blazar
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
Blood 2012;119(6):1570-80.
2011: Douglas E Gladstone; Carol Ann Huff; Richard J Jones; Yvette L Kasamon; Hyam I Levitsky; Leo Luznik; William Matsui; Jonathan D Powell; Richard F Ambinder; F. JAVIER BOLANOS MEADE; Ivan Borrello; Robert A Brodsky; Ian W Flinn; Ephraim J Fuchs; Marianna Zahurak; Lode J Swinnen
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas.
Leukemia & lymphoma 2011;52(11):2076-81.
2011: Amy Elizabeth Dezern; Ephraim J Fuchs; Steven D Gore; Richard J Jones; Judith E Karp; Sharon Kim; Leo Luznik; A MICHAEL MCDEVITT; B Douglas Smith; Anthony Sung; Mark Levis
Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(9):1404-9.
2011: Amy Elizabeth Dezern; Ephraim J Fuchs; Richard J Jones; Leo Luznik; Robert A Brodsky
Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia.
Bone marrow transplantation 2011;46(7):1012-3.
2011: Ashley Munchel; HEATHER SYMONS; Richard J Jones; Yvette L Kasamon; Chimen Kesserwan; Leo Luznik; Ephraim J Fuchs
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide.
Pediatric reports 2011;3 Suppl 2():e15.
2011: F. JAVIER BOLANOS MEADE; B Douglas Smith; Steven D Gore; A MICHAEL MCDEVITT; Leo Luznik; Ephraim J Fuchs; Richard J Jones
5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(5):754-8.
2011: Christopher G Kanakry; Allan Hess; Christopher D Gocke; Christopher J Thoburn; FERDYNAND KOS; Christian Meyer; Janet Briel; Leo Luznik; B Douglas Smith; Hyam I Levitsky; Judith E Karp
Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells.
Blood 2011;117(2):608-17.
2010: Leo Luznik; Richard J Jones; Ephraim J Fuchs
High-dose cyclophosphamide for graft-versus-host disease prevention.
Current opinion in hematology 2010;17(6):493-9.
2010: Leo Luznik; Ephraim J Fuchs
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.
Immunologic research 2010;47(1-3):65-77.
2010: Yvette L Kasamon; Richard J Jones; Robert A Brodsky; Ephraim J Fuchs; William Matsui; Leo Luznik; Jonathan D Powell; Amanda Blackford; Amy Goodrich; Christopher D Gocke; Ross A. Abrams; Richard F Ambinder; Ian W Flinn
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(6):1203-10.
2010: Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert A Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette L Kasamon; Steven Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.
Blood 2010;115(16):3224-30.
2010: Yvette L Kasamon; Leo Luznik; Mary S Leffell; Jeanne Kowalski; Hua-Ling Tsai; F. JAVIER BOLANOS MEADE; Lawrence E Morris; Pamela Crilley; Paul V O'Donnell; Nancy Rossiter; Carol Ann Huff; Robert A Brodsky; William Matsui; Lode J Swinnen; Ivan Borrello; Jonathan D Powell; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(4):482-9.
2010: Robert A Brodsky; Allen R Chen; Donna Dorr; Ephraim J Fuchs; Carol Ann Huff; Leo Luznik; B Douglas Smith; William Matsui; Steven Goodman; Richard F Ambinder; Richard J Jones
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.
Blood 2010;115(11):2136-41.
2010: Vedran Radojcic; Maria A Pletneva; Hung-Rong Yen; Sanja Ivcevic; Angela Panoskaltsis-Mortari; Anita C Gilliam; Charles G Drake; Bruce R Blazar; Leo Luznik
STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(2):764-74.
2010: Vedran Radojcic; Karl B Bezak; Mario Skarica; Maria A Pletneva; Kiyoshi Yoshimura; Richard D Schulick; Leo Luznik
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination.
Cancer immunology, immunotherapy : CII 2010;59(1):137-48.
2009: Ephraim J Fuchs; Leo Luznik; F. JAVIER BOLANOS MEADE; Carole B Miller; Robert A Brodsky; Richard F Ambinder; Richard J Jones
Successful pregnancy and childbirth after reduced-intensity conditioning and partially HLA-mismatched BMT.
Bone marrow transplantation 2009;43(12):969-70.
2009: F. JAVIER BOLANOS MEADE; Leo Luznik; M Muth; William Matsui; Carol Ann Huff; B Douglas Smith; MOSHE LEVY; Yvette L Kasamon; L J Swinnen; Jonathan D Powell; Robert A Brodsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.
Bone marrow transplantation 2009;43(6):477-80.
2008: Lauri M Burroughs; Paul V O'Donnell; Brenda M Sandmaier; Barry E Storer; Leo Luznik; HEATHER SYMONS; Richard J Jones; Richard F Ambinder; Michael B Maris; Karl G Blume; Dietger Niederwieser; Benedetto Bruno; Richard T Maziarz; Michael Allen Pulsipher; Finn B Petersen; Rainer Storb; Ephraim J Fuchs; David G Maloney
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1279-87.
2008: Robert A Brodsky; Leo Luznik; F. JAVIER BOLANOS MEADE; Mary S Leffell; Richard J Jones; Ephraim J Fuchs
Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.
Bone marrow transplantation 2008;42(8):523-7.
2008: Erica D Warlick; Paul V O'Donnell; Michael J Borowitz; Nichon Grupka; Lauren Decloe; Elizabeth Garrett-Mayer; Ivan Borrello; Robert A Brodsky; Ephraim J Fuchs; Carol Ann Huff; Leo Luznik; William Matsui; Richard F Ambinder; Richard J Jones; B Douglas Smith
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.
Leukemia research 2008;32(9):1439-47.
2008: Leo Luznik; Paul V O'Donnell; HEATHER SYMONS; Allen R Chen; Mary S Leffell; Marianna Zahurak; Ted A Gooley; Steven Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; F. JAVIER BOLANOS MEADE; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):641-50.
2008: HEATHER SYMONS; MOSHE LEVY; Jie Wang; Xiaotao Zhou; Gang Zhou; Sarah E Cohen; Leo Luznik; Hyam I Levitsky; Ephraim J Fuchs
The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):499-509.
2007: F. JAVIER BOLANOS MEADE; Elizabeth Garrett-Mayer; Leo Luznik; Viki Anders; Jennifer Webb; Ephraim J Fuchs; Carol Ann Huff; William Matsui; Ivan Borrello; Robert A Brodsky; Yvette L Kasamon; Lode J Swinnen; Ian W Flinn; Richard F Ambinder; Richard J Jones; Allan Hess; Georgia B Vogelsang
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1185-91.
2007: Nadira Durakovic; Vedran Radojcic; Mario Skarica; Karl B Bezak; Jonathan D Powell; Ephraim J Fuchs; Leo Luznik
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.
Blood 2007;109(10):4564-74.
2007: Nadira Durakovic; Vedran Radojcic; Jonathan D Powell; Leo Luznik
Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity.
Transplantation 2007;83(5):631-40.
2006: Nadira Durakovic; Karl B Bezak; Mario Skarica; Vedran Radojcic; Ephraim J Fuchs; George F Murphy; Leo Luznik
Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(7):4414-25.
2006: Leo Luznik
Finding the best way to train the immune system against lymphoma.
Leukemia & lymphoma 2006;47(4):577-9.
2006: Carol Ann Huff; Ephraim J Fuchs; B Douglas Smith; Amanda Blackford; Elizabeth Garrett-Mayer; Robert A Brodsky; Ian W Flinn; Richard F Ambinder; Ivan Borrello; William Matsui; Georgia B Vogelsang; Constance A Griffin; Leo Luznik; Richard J Jones
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):414-21.
2003: Leo Luznik; Paul V O'Donnell; Ephraim J Fuchs
Nonmyeloablative alternative donor transplants.
Current opinion in oncology 2003;15(2):121-6.
2003: Leo Luznik; Jill E Slansky; Sanju Jalla; Ivan Borrello; Hyam I Levitsky; Drew M Pardoll; Ephraim J Fuchs
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras.
Blood 2003;101(4):1645-52.
2002: Leo Luznik; Ephraim J Fuchs
Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.
Cancer control : journal of the Moffitt Cancer Center 2002;9(2):123-37.
2002: Paul V O'Donnell; Leo Luznik; Richard J Jones; Georgia B Vogelsang; Mary S Leffell; Michele Phelps; P Rhubart; K Cowan; S Piantados; Ephraim J Fuchs
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):377-86.
2002: Leo Luznik; Laura Wendy Engstrom; Robert Iannone; Ephraim J Fuchs
Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):131-8.
2001: Leo Luznik; Sanju Jalla; Laura Wendy Engstrom; Robert Iannone; Ephraim J Fuchs
Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.
Blood 2001;98(12):3456-64.
2001: Robert Iannone; Leo Luznik; Laura Wendy Engstrom; Sherrie Tennessee; Frederic B Askin; James F Casella; Thomas S Kickler; Steven Goodman; Anita L Hawkins; Constance A Griffin; L Noffsinger; Ephraim J Fuchs
Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia.
Blood 2001;97(12):3960-5.
1996: O Yamada; Gunter Kraus; Leo Luznik; M Yu; Flossie Wong-Staal
A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.
Journal of virology 1996;70(3):1596-601.
1995: Leo Luznik; M E Martone; Gunter Kraus; Y Zhang; Y Xu; M H Ellisman; Flossie Wong-Staal
Localization of human immunodeficiency virus Rev in transfected and virus-infected cells.
AIDS research and human retroviruses 1995;11(7):795-804.
1995: Leo Luznik; Gunter Kraus; John C Guatelli; D Richman; Flossie Wong-Staal
Tat-independent replication of human immunodeficiency viruses.
The Journal of clinical investigation 1995;95(1):328-32.